Both sunitinib and sorafenib are effective treatments for pheochromocytoma in a xenograft model
- DOI
- 10.1016/j.canlet.2014.07.005
- Published
- 2014-10
- Container
- Cancer Letters
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.canlet.2014.07.005,
title = {Both sunitinib and sorafenib are effective treatments for pheochromocytoma in a xenograft model},
author = {M. Denorme and L. Yon and C. Roux and B.J. Gonzalez and E. Baudin and Y. Anouar and C. Dubessy},
year = {2014},
journal = {Cancer Letters},
doi = {10.1016/j.canlet.2014.07.005},
url = {https://doi.org/10.1016/j.canlet.2014.07.005}
}RIS
TY - JOUR TI - Both sunitinib and sorafenib are effective treatments for pheochromocytoma in a xenograft model AU - M. Denorme AU - L. Yon AU - C. Roux AU - B.J. Gonzalez AU - E. Baudin AU - Y. Anouar AU - C. Dubessy PY - 2014 JO - Cancer Letters DO - 10.1016/j.canlet.2014.07.005 UR - https://doi.org/10.1016/j.canlet.2014.07.005 ER -
APA
Denorme, M., Yon, L., Roux, C., Gonzalez, B., Baudin, E., Anouar, Y., & Dubessy, C. (2014). Both sunitinib and sorafenib are effective treatments for pheochromocytoma in a xenograft model. Cancer Letters. https://doi.org/10.1016/j.canlet.2014.07.005
Source records
- crossref · retrieved 2026-09-26T06:45:44.598Z